Published in Asian J Androl on July 04, 2014
LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion. Mol Biol Cell (2016) 0.81
Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis. Chin J Cancer (2017) 0.77
Involvement of β- and γ-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells. PLoS One (2017) 0.75
Global developments in prostate cancer research and clinical practice. Asian J Androl (2014) 0.75
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Cell migration: a physically integrated molecular process. Cell (1996) 23.49
Dynamic instability of microtubule growth. Nature (1984) 20.32
Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer (2003) 13.01
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol (2005) 10.44
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol (2003) 7.93
Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol (2003) 7.89
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol (2008) 7.30
Cancer invasion and the microenvironment: plasticity and reciprocity. Cell (2011) 6.36
Rac activation and inactivation control plasticity of tumor cell movement. Cell (2008) 6.01
Plasticity of cell migration: a multiscale tuning model. J Cell Biol (2009) 5.82
Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem (2007) 5.36
Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol (2009) 4.39
Reassembly of contractile actin cortex in cell blebs. J Cell Biol (2006) 4.31
Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res (2004) 4.04
Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res (2002) 3.95
Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol (2004) 3.78
ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol (2006) 3.55
Unleashing formins to remodel the actin and microtubule cytoskeletons. Nat Rev Mol Cell Biol (2009) 3.45
Cell motility through plasma membrane blebbing. J Cell Biol (2008) 3.29
Integrins in cell migration. Cold Spring Harb Perspect Biol (2011) 3.15
Role of cortical tension in bleb growth. Proc Natl Acad Sci U S A (2009) 3.08
Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol (2005) 3.02
Mechanical modes of 'amoeboid' cell migration. Curr Opin Cell Biol (2009) 2.99
The tubulin code. Cell Cycle (2007) 2.80
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell (2011) 2.77
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell (2005) 2.65
Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood (2003) 2.40
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol (2008) 2.27
Cancer. The metastasis cascade. Science (2008) 2.19
Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol (2007) 2.17
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res (2009) 2.07
Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate (1999) 2.02
Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc Natl Acad Sci U S A (2011) 1.98
The collection of the motile population of cells from a living tumor. Cancer Res (2000) 1.95
Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol (2013) 1.84
Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. Trends Cell Biol (2011) 1.82
Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev (2007) 1.77
Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol (2006) 1.76
DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol (2008) 1.75
Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene (2006) 1.73
A short history of blebbing. J Microsc (2008) 1.68
Cell mechanics control rapid transitions between blebs and lamellipodia during migration. Proc Natl Acad Sci U S A (2012) 1.67
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell (2008) 1.62
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol (2012) 1.60
Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. J Biol Chem (2008) 1.57
Dia-interacting protein modulates formin-mediated actin assembly at the cell cortex. Curr Biol (2007) 1.56
Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell (2011) 1.54
Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene (2010) 1.50
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol (2009) 1.43
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res (2009) 1.39
An ezrin-rich, rigid uropod-like structure directs movement of amoeboid blebbing cells. J Cell Sci (2011) 1.28
The Diaphanous-related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing. J Biol Chem (2008) 1.20
RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol (2011) 1.17
Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. Proc Natl Acad Sci U S A (2011) 1.14
Prostate cancer and the met hepatocyte growth factor receptor. Adv Cancer Res (2004) 1.13
Large oncosomes mediate intercellular transfer of functional microRNA. Cell Cycle (2013) 1.12
p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol (2010) 1.08
FilGAP, a Rho/Rho-associated protein kinase-regulated GTPase-activating protein for Rac, controls tumor cell migration. Mol Biol Cell (2012) 1.08
EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells. Mol Cancer Res (2011) 1.06
EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. J Mol Med (Berl) (2012) 1.04
The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility. J Cell Sci (2012) 1.01
Targeting stathmin in prostate cancer. Mol Cancer Ther (2005) 1.01
Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One (2010) 1.01
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med (2012) 1.01
Moving in the right direction-nanoimaging in cancer cell motility and metastasis. Microsc Res Tech (2007) 1.00
TACC3 is essential for EGF-mediated EMT in cervical cancer. PLoS One (2013) 1.00
SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. Mol Cancer (2011) 0.98
Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1. Mol Cell Biol (2013) 0.97
Stimulation of cortical myosin phosphorylation by p114RhoGEF drives cell migration and tumor cell invasion. PLoS One (2012) 0.96
ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells. Am J Pathol (2012) 0.92
Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration. PLoS One (2012) 0.90
A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases. Am J Clin Pathol (2012) 0.85
Met-induced membrane blebbing leads to amoeboid cell motility and invasion. Oncogene (2013) 0.85
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells. BMC Cancer (2012) 0.84
Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs. Oncogene (2007) 0.83
Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signaling. PLoS One (2012) 0.83
Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C. J Invest Dermatol (2012) 0.82
Dia-interacting protein (DIP) imposes migratory plasticity in mDia2-dependent tumor cells in three-dimensional matrices. PLoS One (2012) 0.82
Differing and isoform-specific roles for the formin DIAPH3 in plasma membrane blebbing and filopodia formation. Cell Res (2011) 0.82
Tumor suppressor interactions with microtubules: keeping cell polarity and cell division on track. Dis Model Mech (2010) 0.80
Hic-5 affects proliferation, migration and invasion of B16 murine melanoma cells. Pigment Cell Melanoma Res (2012) 0.78
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res (2007) 5.97
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res (2006) 3.07
A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci U S A (2006) 2.89
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int J Cancer (2005) 2.25
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res (2004) 2.07
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res (2009) 2.07
Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem Rev (2005) 1.91
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol (2012) 1.60
Combining results of microarray experiments: a rank aggregation approach. Stat Appl Genet Mol Biol (2006) 1.56
Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem (2004) 1.52
Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol (2004) 1.40
Composite organic-inorganic nanoparticles as Raman labels for tissue analysis. Nano Lett (2007) 1.39
d4eBP acts downstream of both dTOR and dFoxo to modulate cardiac functional aging in Drosophila. Aging Cell (2009) 1.31
Ligand specificity in the CRAL-TRIO protein family. Biochemistry (2003) 1.29
Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res (2005) 1.04
A highly invasive human glioblastoma pre-clinical model for testing therapeutics. J Transl Med (2008) 1.03
Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res (2009) 1.02
Analyzing patterns of staining in immunohistochemical studies: application to a study of prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev (2005) 1.02
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med (2012) 1.01
Raman nanoparticle probes for antibody-based protein detection in tissues. J Histochem Cytochem (2007) 1.00
Structural insight into the self-sacrifice mechanism of enediyne resistance. ACS Chem Biol (2006) 0.96
Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. Int J Cancer (2005) 0.94
Preparation of fluorescent tocopherols for use in protein binding and localization with the alpha-tocopherol transfer protein. Bioorg Med Chem (2006) 0.90
The contribution of surface residues to membrane binding and ligand transfer by the α-tocopherol transfer protein (α-TTP). J Mol Biol (2010) 0.89
Plekhg4 is a novel Dbl family guanine nucleotide exchange factor protein for rho family GTPases. J Biol Chem (2013) 0.88
Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior. Neoplasia (2013) 0.85
Expression and refolding of recombinant human alpha-tocopherol transfer protein capable of specific alpha-tocopherol binding. Protein Expr Purif (2002) 0.83
Hepatic α-tocopherol transfer protein: ligand-induced protection from proteasomal degradation. Biochemistry (2010) 0.82
Active surveillance for prostate cancer: the role of the pathologist. Pathology (2015) 0.82
Effect of bilayer phospholipid composition and curvature on ligand transfer by the alpha-tocopherol transfer protein. Lipids (2009) 0.82
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch (2014) 0.81
Intracellular localization of alpha-tocopherol transfer protein and alpha-tocopherol. Ann N Y Acad Sci (2004) 0.77
Men with nonobstructive azoospermia have Leydig cell hypertrophy but not hyperplasia. J Urol (2002) 0.76
Tocopherol transfer protein sensitizes prostate cancer cells to vitamin E. J Biol Chem (2015) 0.75